Partner Content Partner Content Insightful Developments and an Exclusive Interview from Roch... Ophthalmic Drugs 2018
Partner Content Partner Content Talks from the MHRA, Innovate UK, Plasticell and more Cell and Gene Therapy
Events Partner Content CRISPR Congress Europe 2018 | Genome Evolution Conference Join Precision CRISPR Gene Editing Community in Europe
Partner Content Partner Content Exclusive Interview Released from Santen for Ophthalmic Drug... Exclusive Interview Released from Santen
Partner Content Partner Content Explore New Strategies for Treating Retinal Vascular Disease... Ophthalmic Drugs 2018
Partner Content Partner Content Exclusive Speaker Interview for SMI’s Inaugural Cell & G... Speaker Interview for Cell & Gene Therapy 2018
News Beacon's XLRP gene therapy set for filing after phase 3 win Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
